Clinical Trial

nVNS, CBD, and SoC for Persistent Post-Traumatic Headache

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Do cannabidiol (CBD) or vagus nerve stimulation reduce the frequency of persistent post-traumatic headache more than traditional oral headache medications?
Trial Details
NCT Number NCT07624279
Lead Sponsor American Society of Pain and Neuroscience, Inc.
Collaborators: National Football League
Conditions Persistent Post Traumatic Headache
Enrollment 80 participants
Start Date 2026-06-01
Primary Completion 2027-07-31 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-03